Patents by Inventor Yue Pan

Yue Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200349706
    Abstract: Embodiments of the disclosure provide systems and methods for biomedical image analysis. A method may include receiving a plurality of unannotated biomedical images, including a first image and a second image. The method may also include determining that the first image is in a first view and the second image is in a second view. The method may further include assigning the first image to a first processing path for the first orientation. The method may additionally include assigning the second image to a second processing path for the second view. The method may also include processing the first image in the first processing path in parallel with processing the second image in the second processing path. The first path may share processing parameters with the second path. The method may further include providing a diagnostic output based on the processing of the first image and the second image.
    Type: Application
    Filed: April 29, 2020
    Publication date: November 5, 2020
    Applicant: CURACLOUD CORPORATION
    Inventors: Feng Gao, Hao-Yu Yang, Youbing Yin, Yue Pan, Xin Wang, Junjie Bai, Yi Wu, Kunlin Cao, Qi Song
  • Publication number: 20200349697
    Abstract: Embodiments of the disclosure provide systems and methods for detecting an intracerebral hemorrhage (ICH). The system includes a communication interface configured to receive a sequence of image slices and an end-to-end multi-task learning model. The sequence of image slices is the head scan images of a subject acquired by an image acquisition device. The end-to-end multi-task learning model includes an encoder, a bi-directional Convolutional Recurrent Neural Network (ConvRNN), a decoder, and a classifier. The system further includes at least one processor configured to extract feature maps from each image slice using the encoder, capture contextual information between adjacent image slices using the bi-directional ConvRNN, and detect the ICH of the subject using the classifier based on the extracted feature maps of the image slices and the contextual information or segment each image slice using the decoder to obtain an ICH region based on the extracted feature maps of the image slice.
    Type: Application
    Filed: April 28, 2020
    Publication date: November 5, 2020
    Applicant: CURACLOUD CORPORATION
    Inventors: Feng Gao, Youbing Yin, Danfeng Guo, Pengfei Zhao, Xin Wang, Hao-Yu Yang, Yue Pan, Yi Lu, Junjie Bai, Kunlin Cao, Qi Song, Xiuwen Yu
  • Publication number: 20200313245
    Abstract: Disclosed are a power battery pack safety prevention and control system for an electric vehicle and a control method. The power battery pack safety prevention and control system includes a signal collection device, a master controller, and a stepwise prevention and control actuator. The master controller includes a fault diagnosis device, a cell thermal runway determination device, and a battery pack thermal runway spread determination device which are respectively electrically connected to the stepwise prevention and control actuator and send different control instructions to the stepwise prevention and control actuator. The stepwise prevention and control actuator can perform different levels of prevention and control actions according to different control instructions sent by the fault diagnosis device, the cell thermal runway determination device, and the battery pack thermal runway spread determination device.
    Type: Application
    Filed: June 15, 2020
    Publication date: October 1, 2020
    Applicant: Tsinghua University
    Inventors: XU-NING FENG, XIANG-MING HE, LI WANG, MING-GAO OUYANG, LAN-GUANG LU, YUE PAN
  • Patent number: 10789226
    Abstract: This application generally relates to data processing methods and apparatus. One data processing method disclosed herein comprises: creating a Writable Snapshot based on data modification; creating a plurality of Read-Only (“RO”) Snapshots by cloning the Writable Snapshot at distinct predetermined creation-times; receiving a data inquiry request; and conducting the data inquiry through indexing, in a RO Snapshot with a latest creation-time. This approach achieves separation of data modification and data inquiry, enabling efficient real-time updating. Further, by fast indexing and invert indexing, inquiry efficiency is further improved. Additionally, data is stored in data columns, wherein each column may be divided into multiple data blocks according to a fixed block size, and each data block has a same length.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: September 29, 2020
    Assignee: ALIBABA GROUP HOLDING LIMITED
    Inventors: Chuangxian Wei, Yue Pan, Bowen Zheng, Jienan Zeng
  • Patent number: 10709712
    Abstract: The present invention provides compounds of Formula (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: July 14, 2020
    Assignee: NOVARTIS AG
    Inventors: Robert John Aversa, Paul Andrew Barsanti, Matthew T. Burger, Michael Patrick Dillon, Alan Dipesa, Cheng Hu, Yan Lou, Gisele A. Nishiguchi, Yue Pan, Valery Rostislavovich Polyakov, Savithri Ramurthy, Alice C. Rico, Lina Quattrocchio Setti, Aaron Smith, Sharadha Subramanian, Benjamin R. Taft, Huw Roland Tanner, Lifeng Wan, Naeem Yusuff
  • Patent number: 10660888
    Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: May 26, 2020
    Assignee: NOVARTIS AG
    Inventors: Jeffrey T. Bagdanoff, Yu Ding, Wooseok Han, Zilin Huang, Qun Jiang, Xianming Jin, Xiang Kou, Patrick Lee, Mika Lindvall, Zhongcheng Min, Yue Pan, Sabina Pecchi, Keith Bruce Pfister, Daniel Poon, Vivek Rauniyar, Xiaojing Michael Wang, Qiong Zhang, Jianguang Zhou, Shejin Zhu
  • Publication number: 20200065374
    Abstract: Embodiments of the disclosure provide systems and methods for processing unstructured texts in a medical record. A disclosed system includes at least one processor configured to determine a plurality of word representations of an unstructured text and tag entities in the unstructured text by performing a named entity recognition task on the plurality of word representations. The at least one processor is further configured to determine position embeddings based on positions of words in the unstructured text relative to positions of the tagged entities and concatenate the plurality of word representations with the position embeddings. The at least one processor is also configured to determine relation labels between pairs of tagged entities by performing a relationship extraction task on the concatenated word representations and position embeddings.
    Type: Application
    Filed: August 19, 2019
    Publication date: February 27, 2020
    Applicant: SHENZHEN KEYA MEDICAL TECHNOLOGY CORPORATION
    Inventors: Feng Gao, Changsheng Liu, Yue Pan, Youbing Yin, Kunlin Cao, Qi Song
  • Patent number: 10536514
    Abstract: A method and an apparatus for processing a retransmission request in distributed computing are disclosed. The method includes obtaining a retransmission request to be processed in distributed computing; determining a target copy partition corresponding to the retransmission request based on respective partition response time information of individual copy partitions; sending the retransmission request to the target copy partition. Compared with existing technologies, the present disclosure distinguishes each partition with one another based on a partition response time of the respective copy partition to determine a target copy partition corresponding to a retransmission request, thus selecting a copy with a better response time during retransmission, reducing a response time for the retransmission request and reducing an overall load of an associated cluster.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: January 14, 2020
    Assignee: Alibaba Group Holding Limited
    Inventors: Yicong Huang, Chaoqun Zhan, Yue Pan, Xiang Zhou, Yujun Liao, Jiannan Ji
  • Patent number: 10444237
    Abstract: A hybridoma cell line NM002-1 secreting an anti-human pancreatic cancer monoclonal antibody and deposited under CCTCC Accession NO: C201173. Also, an anti-human pancreatic cancer monoclonal antibody NJ002-1 secreted by the hybridoma cell line NM002-1 and use thereof.
    Type: Grant
    Filed: July 26, 2016
    Date of Patent: October 15, 2019
    Assignee: NANJING MARKERLINE BIOMEDICAL TECHNOLOGY CO., LTD.
    Inventors: Yue Pan, Shiyang Pan, Jian Xu
  • Publication number: 20190247392
    Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
    Type: Application
    Filed: December 5, 2018
    Publication date: August 15, 2019
    Inventors: Jeffrey T. BAGDANOFF, Yu DING, Wooseok HAN, Zilin HUANG, Qun JIANG, Xianming JIN, Xiang KOU, Patrick LEE, Mika LINDVALL, Zhongcheng MIN, Yue PAN, Sabina PECCHI, Keith Bruce PFISTER, Daniel POON, Vivek RAUNIYAR, Xiaojing Michael WANG, Qiong ZHANG, Jianguang ZHOU, Shejin ZHU
  • Publication number: 20190175606
    Abstract: The present invention provides compounds of Formula (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
    Type: Application
    Filed: February 12, 2019
    Publication date: June 13, 2019
    Inventors: Robert John AVERSA, Paul Andrew BARSANTI, Matthew T. BURGER, Michael Patrick DILLON, Alan DIPESA, Cheng HU, Yan LOU, Gisele A. NISHIGUCHI, Yue PAN, Valery Rostislavovich POLYAKOV, Savithri RAMURTHY, Alice C. RICO, Lina Quattrocchio SETTI, Aaron SMITH, Sharadha SUBRAMANIAN, Benjamin R. TAFT, Huw Roland TANNER, Lifeng WAN, Naeem YUSUFF
  • Patent number: 10245267
    Abstract: The present invention provides compounds of Formula (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: April 2, 2019
    Assignee: Novartis AG
    Inventors: Robert John Aversa, Paul Andrew Barsanti, Matthew T. Burger, Michael Patrick Dillon, Alan Dipesa, Cheng Hu, Yan Lou, Gisele A. Nishiguchi, Yue Pan, Valery Rostislavovich Polyakov, Savithri Ramurthy, Alice C. Rico, Lina Quattrocchio Setti, Aaron Smith, Sharadha Subramanian, Benjamin R. Taft, Huw Roland Tanner, Lifeng Wan, Naeem Yusuff
  • Patent number: 10188649
    Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: January 29, 2019
    Assignee: Novartis AG
    Inventors: Jeffrey T. Bagdanoff, Yu Ding, Wooseok Han, Zilin Huang, Qun Jiang, Xianming Jin, Xiang Kou, Patrick Lee, Mika Lindvall, Zhongcheng Min, Yue Pan, Sabina Pecchi, Keith Bruce Pfister, Daniel Poon, Vivek Rauniyar, Xiaojing Michael Wang, Qiong Zhang, Jianguang Zhou, Shejin Zhu
  • Publication number: 20180276264
    Abstract: Embodiments of the present invention provide an index establishment method and device. The method can include determining, according to index status information of a column in a database within a preset time threshold, whether an index is to be established for the column; determining an index type according to the data information of the column; and establishing the index for the column according to the index type based on the determination that the index is to be established for the column.
    Type: Application
    Filed: June 1, 2018
    Publication date: September 27, 2018
    Inventors: Bowen ZHENG, Yue PAN, Chuangxian WEI
  • Publication number: 20180276031
    Abstract: Embodiments of the present application provide a task allocation method and system. The method includes: analyzing at least one query pattern of a target task to acquire expected response time of the query pattern; estimating system cost information and estimated response time according to the query pattern and service description information; estimating node cost information of each processing node of a set of processing nodes in a computing system; selecting a processing node of the set of processing nodes according to the node cost information to allocate subtasks of the target task to the selected processing node; and determining an unallocated subtask in the target task to schedule the unallocated subtask according to the expected response time, the system cost information, and the estimated response time.
    Type: Application
    Filed: March 15, 2018
    Publication date: September 27, 2018
    Inventors: Xiang ZHOU, Jiannan JI, Chaoqun ZHAN, Yue PAN, Yujun LIAO
  • Publication number: 20180224457
    Abstract: A hybridoma cell line NM002-1 secreting an anti-human pancreatic cancer monoclonal antibody and deposited under CCTCC Accession NO: C201173. Also, an anti-human pancreatic cancer monoclonal antibody NJ002-1 secreted by the hybridoma cell line NM002-1 and use thereof.
    Type: Application
    Filed: July 26, 2016
    Publication date: August 9, 2018
    Applicant: NANJING MARKERLINE BIOMEDICAL TECHNOLOGY CO., LTD.
    Inventors: Yue PAN, Shiyang PAN, Jian XU
  • Patent number: 9953638
    Abstract: A computer-implemented method is described for front end speech processing for automatic speech recognition. A sequence of speech features which characterize an unknown speech input provided on an audio input channel and associated meta-data which characterize the audio input channel are received. The speech features are transformed with a computer process that uses a trained mapping function controlled by the meta-data, and automatic speech recognition is performed of the transformed speech features.
    Type: Grant
    Filed: June 28, 2012
    Date of Patent: April 24, 2018
    Assignee: Nuance Communications, Inc.
    Inventors: Daniel Willett, Karl Jonas Lööf, Yue Pan, Joel Pinto, Christian Gollan
  • Publication number: 20180028532
    Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
    Type: Application
    Filed: August 9, 2017
    Publication date: February 1, 2018
    Applicant: Novartis AG
    Inventors: Jeffrey T. BAGDANOFF, Yu DING, Wooseok HAN, Zilin HUANG, Qun JIANG, Xianming JIN, Xiang KOU, Patrick LEE, Mika LINDVALL, Zhongcheng MIN, Yue PAN, Sabina PECCHI, Keith Bruce PFISTER, Daniel POON, Vivek RAUNIYAR, Xiaojing Michael WANG, Qiong ZHANG, Jianguang ZHOU, Shejin ZHU
  • Patent number: 9798858
    Abstract: A method, a system, and a computer readable article of manufacture tangibly embodying computer readable instructions for executing a computer implemented method for automatically evaluating the quality of a medical record. The method includes: generating temporary facts from a medical record to be evaluated; constructing a query to a knowledge base of standard facts of standard medical records from the temporary facts; executing the query to the knowledge base by using a reasoning engine; and determining the quality of a medical record to be evaluated based on the result of the query.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: October 24, 2017
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Bo Li, Xue Qiao Hou, Hui-I Hsiao, Gang Hu, Yue Pan
  • Patent number: 9763937
    Abstract: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: September 19, 2017
    Assignee: Novartis AG
    Inventors: Jeffrey T. Bagdanoff, Yu Ding, Wooseok Han, Zilin Huang, Qun Jiang, Xianming Jin, Xiang Kou, Patrick Lee, Mika Lindvall, Zhongcheng Min, Yue Pan, Sabina Pecchi, Keith Bruce Pfister, Daniel Poon, Vivek Rauniyar, Xiaojing Michael Wang, Qiong Zhang, Jianguang Zhou, Shejin Zhu